FDA Inspection 1067227 — Midwest Transplant Network

Midwest Transplant Network — FEI 3001238375

The FDA completed an inspection of Midwest Transplant Network on September 13, 2018 in Westwood, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 13, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Westwood, KS (United States)